Legal Representation
Attorney
Lori K. Hall
USPTO Deadlines
Application History
15 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Nov 6, 2014 | MAB1 | O | ABANDONMENT NOTICE MAILED - EXPRESS ABANDONMENT | Loading... |
| Nov 6, 2014 | ABN1 | O | ABANDONMENT - EXPRESS MAILED | Loading... |
| Nov 5, 2014 | EXAR | I | TEAS EXPRESS ABANDONMENT RECEIVED | Loading... |
| Jun 20, 2014 | GNS3 | O | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | Loading... |
| Jun 20, 2014 | GNSL | S | LETTER OF SUSPENSION E-MAILED | Loading... |
| Jun 20, 2014 | CNSL | R | SUSPENSION LETTER WRITTEN | Loading... |
| Jun 3, 2014 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Jun 3, 2014 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| May 23, 2014 | ALIE | A | ASSIGNED TO LIE | Loading... |
| May 12, 2014 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Nov 18, 2013 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Nov 18, 2013 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Nov 18, 2013 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Nov 13, 2013 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Aug 6, 2013 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparation for treating mitochondrial disorders, and diseases or conditions relating to mitochondrial dysfunction or deficiencies including obesity, diabetes, metabolic syndrome, and hypoglycemia; pharmaceutical namely oral, inhalational, parenteral, topical pharmaceuticals containing proteins, protein kinase or phosphatas; nutraceuticals, vitamins, minerals, nutritional and dietary supplements for the treatment of mitochondria disorders, deficiencies or conditions arising from mitochondrial dysfunction or deficiencies
First Use Anywhere:
0
First Use in Commerce:
0
Class 042
Medical and scientific research in the field of mitochondrial disorders, and diseases or conditions relating to mitochondrial dysfunction or deficiencies including obesity, diabetes, metabolic syndrome, and hypoglycemia; Medical research; Pharmaceutical research and development
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
005
042